{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T23:17:53Z","timestamp":1785453473324,"version":"3.56.0"},"reference-count":128,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["R21 MH104505"],"award-info":[{"award-number":["R21 MH104505"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["R21 MH105732"],"award-info":[{"award-number":["R21 MH105732"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["R21 MH097470"],"award-info":[{"award-number":["R21 MH097470"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["1U24MH081810"],"award-info":[{"award-number":["1U24MH081810"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000051","name":"National Human Genome Research Institute","doi-asserted-by":"publisher","award":["UM1HG006542"],"award-info":[{"award-number":["UM1HG006542"]}],"id":[{"id":"10.13039\/100000051","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS058529"],"award-info":[{"award-number":["R01NS058529"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R35NS105078"],"award-info":[{"award-number":["R35NS105078"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009160","name":"Lawrence Ellison Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009160","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000863","name":"Ellison Medical Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000863","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001121","name":"George F. and Sybil H. Fuller Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001121","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015014","name":"Fuller Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015014","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["T32HL079888"],"award-info":[{"award-number":["T32HL079888"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016685","name":"Baylor-Hopkins Center for Mendelian Genomics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016685","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R01GM106373"],"award-info":[{"award-number":["R01GM106373"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["biologicalpsychiatryjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biological Psychiatry"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.biopsych.2019.04.031","type":"journal-article","created":{"date-parts":[[2019,5,9]],"date-time":"2019-05-09T13:19:03Z","timestamp":1557407943000},"page":"523-535","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Targeted Treatment of Individuals With Psychosis Carrying a Copy Number Variant Containing a Genomic Triplication of the Glycine Decarboxylase Gene"],"prefix":"10.1016","volume":"86","author":[{"given":"J. Alexander","family":"Bodkin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Coleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1253-1661","authenticated-orcid":false,"given":"Laura J.","family":"Godfrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia M.B.","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charity J.","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond F.","family":"Suckow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thea","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dost","family":"\u00d6ng\u00fcr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc J.","family":"Kaufman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1477-6187","authenticated-orcid":false,"given":"Kathryn E.","family":"Lewandowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6795-5229","authenticated-orcid":false,"given":"Arthur J.","family":"Siegel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elliot","family":"Waldstreicher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher M.","family":"Grochowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel C.","family":"Javitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Rujescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Hebbring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Weinshilboum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie Burgos","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colette","family":"Kirchhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Visscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7352-4070","authenticated-orcid":false,"given":"Alexander","family":"Vuckovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1314-923X","authenticated-orcid":false,"given":"Allison","family":"Fialkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shane","family":"McCarthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dheeraj","family":"Malhotra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Sebat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald C.","family":"Goff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James I.","family":"Hudson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James R.","family":"Lupski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph T.","family":"Coyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Rudolph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah L.","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopsych.2019.04.031_bib1","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1192\/bjp.bp.113.131052","article-title":"Analysis of copy number variations at 15 schizophrenia-associated loci","volume":"204","author":"Rees","year":"2014","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.biopsych.2019.04.031_bib2","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/j.cell.2012.02.039","article-title":"CNVs: Harbinger of a rare variant revolution in psychiatric genetics","volume":"148","author":"Malhotra","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.biopsych.2019.04.031_bib3","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/ng.3725","article-title":"Contribution of copy number variants to schizophrenia from a genome-wide study of 41,321 subjects","volume":"49","author":"Marshall","year":"2017","journal-title":"Nat Genet"},{"key":"10.1016\/j.biopsych.2019.04.031_bib4","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature07239","article-title":"Rare chromosomal deletions and duplications increase risk of schizophrenia","volume":"455","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.biopsych.2019.04.031_bib5","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/nature07229","article-title":"Large recurrent microdeletions associated with schizophrenia","volume":"455","author":"Stefansson","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.biopsych.2019.04.031_bib6","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1038\/ng.474","article-title":"Microduplications of 16p11.2 are associated with schizophrenia","volume":"41","author":"McCarthy","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.biopsych.2019.04.031_bib7","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.neuron.2008.04.007","article-title":"Schizophrenia: Genome, interrupted","volume":"58","author":"Cantor","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.biopsych.2019.04.031_bib8","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1056\/NEJMoa075974","article-title":"Association between microdeletion and microduplication at 16p11.2 and autism","volume":"358","author":"Weiss","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.biopsych.2019.04.031_bib9","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1056\/NEJMra1114194","article-title":"Genomics, intellectual disability, and autism","volume":"366","author":"Mefford","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.biopsych.2019.04.031_bib10","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1146\/annurev-neuro-071714-034136","article-title":"The genetics of neuropsychiatric diseases: Looking in and beyond the exome","volume":"38","author":"Heinzen","year":"2015","journal-title":"Ann Rev Neurosci"},{"key":"10.1016\/j.biopsych.2019.04.031_bib11","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.biopsych.2013.07.022","article-title":"The penetrance of copy number variations for schizophrenia and developmental delay","volume":"75","author":"Kirov","year":"2014","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2019.04.031_bib12","doi-asserted-by":"crossref","first-page":"R45","DOI":"10.1093\/hmg\/ddv253","article-title":"CNVs in neuropsychiatric disorders","volume":"24","author":"Kirov","year":"2015","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.biopsych.2019.04.031_bib13","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nrg3240","article-title":"Genetic architectures of psychiatric disorders: The emerging picture and its implications","volume":"13","author":"Sullivan","year":"2012","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.biopsych.2019.04.031_bib14","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1126\/science.aaa8954","article-title":"Genetics and genomics of psychiatric disease","volume":"349","author":"Geschwind","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.biopsych.2019.04.031_bib15","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/nature13595","article-title":"Biological insights from 108 schizophrenia-associated genetic loci","volume":"511","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.biopsych.2019.04.031_bib16","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.neuron.2015.09.016","article-title":"Insights into autism spectrum disorder genomic architecture and biology from 71 risk loci","volume":"87","author":"Sanders","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.biopsych.2019.04.031_bib17","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nature09884","article-title":"Duplications of the neuropeptide receptor gene VIPR2 confer significant risk for schizophrenia","volume":"471","author":"Vacic","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.biopsych.2019.04.031_bib18","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1038\/ng.279","article-title":"Recurrent reciprocal 1q21.1 deletions and duplications associated with microcephaly or macrocephaly and developmental and behavioral abnormalities","volume":"40","author":"Brunetti-Pierri","year":"2008","journal-title":"Nat Genet"},{"key":"10.1016\/j.biopsych.2019.04.031_bib19","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMoa0805384","article-title":"Recurrent rearrangements of chromosome 1q21.1 and variable pediatric phenotypes","volume":"359","author":"Mefford","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.biopsych.2019.04.031_bib20","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1176\/appi.ajp.2010.10060876","article-title":"Copy number variants in schizophrenia: Confirmation of five previous findings and new evidence for 3q29 microdeletions and VIPR2 duplications","volume":"168","author":"Levinson","year":"2011","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2019.04.031_bib21","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1038\/ng.481","article-title":"A\u00a0small recurrent deletion within 15q13.3 is associated with a range of neurodevelopmental phenotypes","volume":"41","author":"Shinawi","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.biopsych.2019.04.031_bib22","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/nrg.2015.25","article-title":"Mechanisms underlying structural variant formation in genomic disorders","volume":"17","author":"Carvalho","year":"2016","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.biopsych.2019.04.031_bib23","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/nn.3922","article-title":"Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways","volume":"18","year":"2015","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.biopsych.2019.04.031_bib24","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/nrg3934","article-title":"Systems biology and gene networks in neurodevelopmental and neurodegenerative disorders","volume":"16","author":"Parikshak","year":"2015","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.biopsych.2019.04.031_bib25","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.neuron.2015.04.022","article-title":"Novel findings from CNVs implicate inhibitory and excitatory signaling complexes in schizophrenia","volume":"86","author":"Pocklington","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.biopsych.2019.04.031_bib26","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1177\/0269881114553647","article-title":"Recent genetic findings in schizophrenia and their therapeutic relevance","volume":"29","author":"Harrison","year":"2015","journal-title":"J\u00a0Psychopharmacol"},{"key":"10.1016\/j.biopsych.2019.04.031_bib27","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.cell.2014.02.002","article-title":"A\u00a0genotype-first approach to defining the subtypes of a complex disease","volume":"156","author":"Stessman","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.biopsych.2019.04.031_bib28","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13073-015-0253-0","article-title":"POGZ truncating alleles cause syndromic intellectual disability","volume":"8","author":"White","year":"2016","journal-title":"Genome Med"},{"key":"10.1016\/j.biopsych.2019.04.031_bib29","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/DBP.0b013e3181cda67e","article-title":"Cognitive and behavioral characterization of the Potocki-Lupski syndrome (duplication 17p11.2)","volume":"31","author":"Treadwell-Deering","year":"2010","journal-title":"J\u00a0Dev Behav Pediatr"},{"key":"10.1016\/j.biopsych.2019.04.031_bib30","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/GIM.0b013e3180986192","article-title":"Speech delay and autism spectrum behaviors are frequently associated with duplication of the 7q11.23 Williams-Beuren syndrome region","volume":"9","author":"Berg","year":"2007","journal-title":"Genet Med"},{"key":"10.1016\/j.biopsych.2019.04.031_bib31","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1136\/jmg.2008.064378","article-title":"Microdeletion 15q13.3: A locus with incomplete penetrance for autism, mental retardation, and psychiatric disorders","volume":"46","author":"Ben-Shachar","year":"2009","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.biopsych.2019.04.031_bib32","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1001\/jama.2015.4845","article-title":"Copy number variations and cognitive phenotypes in unselected populations","volume":"313","author":"M\u00e4nnik","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.biopsych.2019.04.031_bib33","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s00439-016-1682-6","article-title":"Clinical genomics: From a truly personal genome viewpoint","volume":"135","author":"Lupski","year":"2016","journal-title":"Hum Genet"},{"key":"10.1016\/j.biopsych.2019.04.031_bib34","unstructured":"Scolnick EM (2010): 3rd Annual Report: January 2010\u2014Executive Summary Version. Available at: https:\/\/www.broadinstitute.org\/files\/shared\/psych\/_StanleyCenterAnnualReportExecSum2009.pdf. Accessed August 14, 2016."},{"key":"10.1016\/j.biopsych.2019.04.031_bib35","doi-asserted-by":"crossref","first-page":"87re83","DOI":"10.1126\/scitranslmed.3002243","article-title":"Whole-genome sequencing for optimized patient management","volume":"3","author":"Bainbridge","year":"2011","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.biopsych.2019.04.031_bib36","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/GIM.0b013e3182088158","article-title":"Making a definitive diagnosis: Successful clinical application of whole exome sequencing in a child with\u00a0intractable inflammatory bowel disease","volume":"13","author":"Worthey","year":"2011","journal-title":"Genet Med"},{"key":"10.1016\/j.biopsych.2019.04.031_bib37","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/ng.379","article-title":"HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin","volume":"41","author":"Daly","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.biopsych.2019.04.031_bib38","doi-asserted-by":"crossref","first-page":"10208","DOI":"10.1073\/pnas.0907011107","article-title":"PIK3CA mutations associated with gene signature of low mTORC1 signaling and better outcomes in estrogen receptor-positive breast cancer","volume":"107","author":"Loi","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2019.04.031_bib39","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1056\/NEJMoa1108046","article-title":"Adenovirus-associated virus vector\u2013mediated gene transfer in Hemophilia B","volume":"365","author":"Nathwani","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.biopsych.2019.04.031_bib40","series-title":"Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)","year":"1994"},{"key":"10.1016\/j.biopsych.2019.04.031_bib41","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.neuron.2011.11.007","article-title":"High frequencies of de novo CNVs in bipolar disorder and schizophrenia","volume":"72","author":"Malhotra","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.biopsych.2019.04.031_bib42","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1002\/humu.23537","article-title":"Marker chromosome genomic structure and temporal origin implicate a chromoanasynthesis event in a family with pleiotropic psychiatric phenotypes","volume":"39","author":"Grochowski","year":"2018","journal-title":"Hum Mutat"},{"key":"10.1016\/j.biopsych.2019.04.031_bib43","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/jnc.13204","article-title":"Time and space profiling of NMDA receptor co-agonist functions","volume":"135","author":"Mothet","year":"2015","journal-title":"J\u00a0Neurochem"},{"key":"10.1016\/j.biopsych.2019.04.031_bib44","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1001\/archpsyc.1995.03950240016004","article-title":"Glutamate receptor dysfunction and schizophrenia","volume":"52","author":"Olney","year":"1995","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2019.04.031_bib45","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s10571-006-9062-8","article-title":"Glutamate and schizophrenia: Beyond the dopamine hypothesis","volume":"26","author":"Coyle","year":"2006","journal-title":"Cell Mol Neurobiol"},{"key":"10.1016\/j.biopsych.2019.04.031_bib46","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1001\/archpsyc.59.7.663","article-title":"Effects of NMDA receptor antagonists: Implications for the pathophysiology of schizophrenia","volume":"59","author":"Krystal","year":"2002","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2019.04.031_bib47","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1176\/appi.ajp.158.9.1367","article-title":"The emerging role of glutamate in the pathophysiology and treatment of schizophrenia","volume":"158","author":"Goff","year":"2001","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2019.04.031_bib48","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1113\/jphysiol.1990.sp018288","article-title":"Competitive antagonists and partial agonists at the glycine modulatory site of the mouse N-methyl-D-aspartate receptor","volume":"430","author":"Henderson","year":"1990","journal-title":"J\u00a0Physiol"},{"key":"10.1016\/j.biopsych.2019.04.031_bib49","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/0006-8993(90)90745-W","article-title":"D-cycloserine acts as a partial agonist at the glycine modulatory site of the NMDA receptor expressed in Xenopus oocytes","volume":"510","author":"Watson","year":"1990","journal-title":"Brain Res"},{"key":"10.1016\/j.biopsych.2019.04.031_bib50","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","article-title":"The Brief Psychiatric Rating Scale","volume":"10","author":"Overall","year":"1962","journal-title":"Psychol Rep"},{"key":"10.1016\/j.biopsych.2019.04.031_bib51","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The Positive and Negative Syndrome Scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.biopsych.2019.04.031_bib52","series-title":"ECDEU Assessment Manual for Psychopharmacology","first-page":"125","article-title":"Clinical global impression (CGI) Scale","author":"Guy","year":"1976"},{"key":"10.1016\/j.biopsych.2019.04.031_bib53","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A\u00a0rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.biopsych.2019.04.031_bib54","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1192\/bjp.133.5.429","article-title":"A\u00a0rating scale for mania: Reliability, validity and sensitivity","volume":"133","author":"Young","year":"1978","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.biopsych.2019.04.031_bib55","series-title":"Columbia\u2013Suicide Severity Rating Scale (C-SSRS)","author":"Posner","year":"2009"},{"issue":"suppl 44","key":"10.1016\/j.biopsych.2019.04.031_bib56","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1600-0447.1970.tb02066.x","article-title":"A\u00a0rating scale for extrapyramidal side effects","volume":"212","author":"Simpson","year":"1970","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.biopsych.2019.04.031_bib57","series-title":"ECDEU Assessment Manual for Psychopharmacology, rev","first-page":"118","article-title":"Abnormal Involuntary Movement Scale (AIMS)","author":"Guy","year":"1976"},{"key":"10.1016\/j.biopsych.2019.04.031_bib58","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/BF00307714","article-title":"Dose-dependent half-life of glycine","volume":"21","author":"Hahn","year":"1993","journal-title":"Urol Res"},{"key":"10.1016\/j.biopsych.2019.04.031_bib59","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1001\/archpsyc.56.1.29","article-title":"Efficacy of high-dose glycine in the treatment of enduring negative symptoms of schizophrenia","volume":"56","author":"Heresco-Levy","year":"1999","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2019.04.031_bib60","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0006-3223(03)00707-8","article-title":"High-dose glycine added to olanzapine and risperidone for the treatment of schizophrenia","volume":"55","author":"Heresco-Levy","year":"2004","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2019.04.031_bib61","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1001\/archpsyc.56.1.21","article-title":"A\u00a0placebo-controlled trial of D-cycloserine added to conventional neuroleptics in patients with schizophrenia","volume":"56","author":"Goff","year":"1999","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2019.04.031_bib62","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1176\/ajp.153.12.1628","article-title":"D-cycloserine added to clozapine for patients with schizophrenia","volume":"153","author":"Goff","year":"1996","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2019.04.031_bib63","first-page":"46","article-title":"An autoradiographic study of the distribution of tritium-labeled cycloserine in mice","volume":"12","author":"Hanngren","year":"1961","journal-title":"Antibiot Chemother"},{"key":"10.1016\/j.biopsych.2019.04.031_bib64","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0304-3940(89)90379-0","article-title":"D-cycloserine: A ligand for the N-methyl-D-aspartate coupled glycine receptor has partial agonist characteristics","volume":"98","author":"Hood","year":"1989","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.biopsych.2019.04.031_bib65","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/0028-3908(91)90161-4","article-title":"Actions of D-cycloserine at the N-methyl-D-aspartate-associated glycine receptor site in\u00a0vivo","volume":"30","author":"Emmett","year":"1991","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopsych.2019.04.031_bib66","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0006-8993(91)91668-Q","article-title":"D-cycloserine, a putative cognitive enhancer, facilitates activation of the N-methyI-D-aspartate receptor-ionophore complex in Alzheimer brain","volume":"565","author":"Chessell","year":"1991","journal-title":"Brain Res"},{"key":"10.1016\/j.biopsych.2019.04.031_bib67","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/s00213-004-2032-2","article-title":"A\u00a0six-month, placebo-controlled trial of D-cycloserine co-administered with conventional antipsychotics in schizophrenia patients","volume":"179","author":"Goff","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.biopsych.2019.04.031_bib68","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.schres.2011.05.029","article-title":"D-cycloserine facilitation of cognitive behavioral therapy for delusions in schizophrenia","volume":"131","author":"Gottlieb","year":"2011","journal-title":"Schizophr Res"},{"key":"10.1016\/j.biopsych.2019.04.031_bib69","series-title":"Randomization Tests","author":"Edgington","year":"2007"},{"key":"10.1016\/j.biopsych.2019.04.031_bib70","doi-asserted-by":"crossref","first-page":"27782","DOI":"10.1074\/jbc.M111814200","article-title":"Direct calcium binding results in activation of brain serine racemase","volume":"277","author":"Cook","year":"2002","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.biopsych.2019.04.031_bib71","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1034\/j.1600-0447.2002.01331.x","article-title":"Antipsychotic combination therapy in schizophrenia: A review of efficacy and risks of current combinations","volume":"106","author":"Freudenreich","year":"2002","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.biopsych.2019.04.031_bib72","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/nrg3046","article-title":"Needles in stacks of needles: Finding disease-causal variants in a wealth of genomic data","volume":"12","author":"Cooper","year":"2011","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.biopsych.2019.04.031_bib73","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1097\/GIM.0b013e318183f848","article-title":"Contemplating effects of genomic structural variation","volume":"10","author":"Buchanan","year":"2008","journal-title":"Genet Med"},{"key":"10.1016\/j.biopsych.2019.04.031_bib74","doi-asserted-by":"crossref","first-page":"340ed348","DOI":"10.1126\/scitranslmed.aaf6146","article-title":"Treating the enigmatic \u201cexceptional responders\u201d as patients with undiagnosed diseases","volume":"8","author":"Perakslis","year":"2016","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.biopsych.2019.04.031_bib75","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1001\/jamapsychiatry.2014.257","article-title":"Bitopertin: The good news and bad news","volume":"71","author":"Goff","year":"2014","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.biopsych.2019.04.031_bib76","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1634\/theoncologist.2014-0476","article-title":"Exceptional responders inspire change: Lessons for drug development from the bedside to the bench and back","volume":"20","author":"Chau","year":"2015","journal-title":"Oncologist"},{"key":"10.1016\/j.biopsych.2019.04.031_bib77","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1126\/science.1226344","article-title":"Genome sequencing identifies a basis for everolimus sensitivity","volume":"338","author":"Iyer","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.biopsych.2019.04.031_bib78","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/32c8d343-9e1d-46c6-bfd4-b0cd3fb7a97e","article-title":"Genic intolerance to functional variation and the interpretation of personal genomes","volume":"9","author":"Petrovski","year":"2013","journal-title":"PLoS Genet"},{"key":"10.1016\/j.biopsych.2019.04.031_bib79","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.ajhg.2014.01.017","article-title":"Mechanism, prevalence, and more severe neuropathy phenotype of the Charcot-Marie-Tooth type 1A triplication","volume":"94","author":"Liu","year":"2014","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.biopsych.2019.04.031_bib80","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/ana.21715","article-title":"Autism and other neuropsychiatric symptoms are prevalent in individuals with MECP2 duplication syndrome","volume":"66","author":"Ramocki","year":"2009","journal-title":"Ann Neurol"},{"key":"10.1016\/j.biopsych.2019.04.031_bib81","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1038\/ng.944","article-title":"Inverted genomic segments and complex triplication rearrangements are mediated by inverted repeats in the human genome","volume":"43","author":"Carvalho","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.biopsych.2019.04.031_bib82","doi-asserted-by":"crossref","first-page":"522","DOI":"10.2174\/138161210790361452","article-title":"Strategies to enhance N-methyl-D-aspartate receptor-mediated neurotransmission in schizophrenia: A critical review and meta-analysis","volume":"16","author":"Tsai","year":"2010","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.biopsych.2019.04.031_bib83","doi-asserted-by":"crossref","first-page":"859","DOI":"10.2165\/11586650-000000000-00000","article-title":"Meta-analysis of the efficacy of adjunctive NMDA receptor modulators in chronic schizophrenia","volume":"25","author":"Singh","year":"2011","journal-title":"CNS Drugs"},{"key":"10.1016\/j.biopsych.2019.04.031_bib84","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/mp.2011.154","article-title":"De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia","volume":"17","author":"Kirov","year":"2012","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.biopsych.2019.04.031_bib85","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1000534","article-title":"Identifying relationships among genomic disease regions: Predicting genes at pathogenic SNP associations and rare deletions","volume":"5","author":"Raychaudhuri","year":"2009","journal-title":"PLoS Genet"},{"key":"10.1016\/j.biopsych.2019.04.031_bib86","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.ajhg.2011.02.001","article-title":"Excess of de novo deleterious mutations in genes associated with glutamatergic systems in nonsyndromic intellectual disability","volume":"88","author":"Hamdan","year":"2011","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.biopsych.2019.04.031_bib87","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/mp.2009.57","article-title":"Rare structural variants found in attention-deficit hyperactivity disorder are preferentially associated with neurodevelopmental genes","volume":"15","author":"Elia","year":"2010","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.biopsych.2019.04.031_bib88","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41398-017-0061-y","article-title":"Rare loss of function mutations in N-methyl-D-aspartate glutamate receptors and their contributions to schizophrenia susceptibility","volume":"8","author":"Yu","year":"2018","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.biopsych.2019.04.031_bib89","doi-asserted-by":"crossref","first-page":"434","DOI":"10.3389\/fgene.2018.00434","article-title":"Common and rare genetic risk factors converge in protein interaction networks underlying schizophrenia","volume":"9","author":"Chang","year":"2018","journal-title":"Front Genet"},{"key":"10.1016\/j.biopsych.2019.04.031_bib90","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1016\/j.jacc.2015.02.049","article-title":"Developing medicines that mimic the natural successes of the human genome: Lessons from NPC1L1, HMGCR, PCSK9, APOC3, and CETP","volume":"65","author":"Kathiresan","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.biopsych.2019.04.031_bib91","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1176\/appi.ajp.2017.17060638","article-title":"Developmental delay, treatment-resistant psychosis, and early-onset dementia in a man with 22q11 deletion syndrome and Huntington\u2019s disease","volume":"175","author":"Farrell","year":"2018","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2019.04.031_bib92","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/j.biopsych.2015.09.017","article-title":"Paradoxical improvement of schizophrenic symptoms by a dopaminergic agonist: An example of personalized psychiatry in a CNV carrying patient","volume":"80","author":"Alexandre","year":"2016","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2019.04.031_bib93","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0169-328X(01)00225-X","article-title":"Structure and expression of the glycine cleavage system in rat central nervous system","volume":"94","author":"Sakata","year":"2001","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/j.biopsych.2019.04.031_bib94","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.tins.2016.09.007","article-title":"The rise and fall of the D-serine-mediated gliotransmission hypothesis","volume":"39","author":"Wolosker","year":"2016","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.biopsych.2019.04.031_bib95","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1111\/j.1471-4159.1989.tb01881.x","article-title":"A\u00a0glycine site associated with N-methyl-D-aspartic acid receptors: Characterization and identification of a new class of antagonists","volume":"52","author":"Kessler","year":"1989","journal-title":"J\u00a0Neurochem"},{"key":"10.1016\/j.biopsych.2019.04.031_bib96","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/S0022-3565(24)37160-5","article-title":"Novel systemically active antagonists of the glycine site of the N-methyl-D-aspartate receptor: Electrophysiological, biochemical and behavioral characterization","volume":"283","author":"Parsons","year":"1997","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.biopsych.2019.04.031_bib97","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0014-2999(88)90367-6","article-title":"Kynurenic acid antagonises responses to NMDA via an action at the strychnine-insensitive glycine receptor","volume":"154","author":"Birch","year":"1988","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.biopsych.2019.04.031_bib98","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1002334","article-title":"Relative burden of large CNVs on a range of neurodevelopmental phenotypes","volume":"7","author":"Girirajan","year":"2011","journal-title":"PLoS Genet"},{"key":"10.1016\/j.biopsych.2019.04.031_bib99","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/ng.835","article-title":"Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations","volume":"43","author":"O\u2019Roak","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.biopsych.2019.04.031_bib100","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1523\/JNEUROSCI.5390-09.2010","article-title":"Structural determinants of D-cycloserine efficacy at the NR1\/NR2C NMDA receptors","volume":"30","author":"Dravid","year":"2010","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.biopsych.2019.04.031_bib101","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.euroneuro.2013.10.006","article-title":"D-cycloserine lowers kynurenic acid formation\u2014New mechanism of action","volume":"24","author":"Baran","year":"2014","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.biopsych.2019.04.031_bib102","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1124\/jpet.107.123109","article-title":"Competitive antagonism between the nicotinic allosteric potentiating ligand galantamine and kynurenic acid at alpha7* nicotinic receptors","volume":"322","author":"Lopes","year":"2007","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.biopsych.2019.04.031_bib103","doi-asserted-by":"crossref","first-page":"7463","DOI":"10.1523\/JNEUROSCI.21-19-07463.2001","article-title":"The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: Physiopathological implications","volume":"21","author":"Hilmas","year":"2001","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.biopsych.2019.04.031_bib104","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/s12031-009-9235-2","article-title":"The astrocyte-derived alpha7 nicotinic receptor antagonist kynurenic acid controls extracellular glutamate levels in the prefrontal cortex","volume":"40","author":"Wu","year":"2010","journal-title":"J\u00a0Mol Neurosci"},{"key":"10.1016\/j.biopsych.2019.04.031_bib105","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.bcp.2012.12.014","article-title":"Kynurenic acid as an antagonist of \u03b17 nicotinic acetylcholine receptors in the brain: Facts and challenges","volume":"85","author":"Albuquerque","year":"2013","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.biopsych.2019.04.031_bib106","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1073\/pnas.94.2.587","article-title":"Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus","volume":"94","author":"Freedman","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2019.04.031_bib107","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1002\/ajmg.1549","article-title":"Evidence of linkage disequilibrium between the alpha 7-nicotinic receptor gene (CHRNA7) locus and schizophrenia in Azorean families","volume":"105","author":"Xu","year":"2001","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.biopsych.2019.04.031_bib108","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1152\/physrev.00015.2008","article-title":"Mammalian nicotinic acetylcholine receptors: From structure to function","volume":"89","author":"Albuquerque","year":"2009","journal-title":"Physiol Rev"},{"key":"10.1016\/j.biopsych.2019.04.031_bib109","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1615\/CritRevNeurobiol.v18.i1-2.80","article-title":"Hippocampal long-term synaptic plasticity and signal amplification of NMDA receptors","volume":"18","author":"MacDonald","year":"2006","journal-title":"Crit Rev Neurobiol"},{"key":"10.1016\/j.biopsych.2019.04.031_bib110","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/ng.162","article-title":"Strong association of de novo copy number mutations with sporadic schizophrenia","volume":"40","author":"Xu","year":"2008","journal-title":"Nat Genet"},{"key":"10.1016\/j.biopsych.2019.04.031_bib111","doi-asserted-by":"crossref","first-page":"16746","DOI":"10.1073\/pnas.0908584106","article-title":"Elucidating the genetic architecture of familial schizophrenia using rare copy number variant and linkage scans","volume":"106","author":"Xu","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2019.04.031_bib112","doi-asserted-by":"crossref","first-page":"6677","DOI":"10.1093\/hmg\/ddu379","article-title":"De novo CNVs in bipolar affective disorder and schizophrenia","volume":"23","author":"Georgieva","year":"2014","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.biopsych.2019.04.031_bib113","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nrn3257","article-title":"Kynurenines in the mammalian brain: When physiology meets pathology","volume":"13","author":"Schwarcz","year":"2012","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.biopsych.2019.04.031_bib114","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.neuropharm.2015.10.028","article-title":"Inhibition of kynurenine aminotransferase II reduces activity of midbrain dopamine neurons","volume":"102","author":"Linderholm","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopsych.2019.04.031_bib115","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1038\/npp.2010.39","article-title":"Reduction of endogenous kynurenic acid formation enhances extracellular glutamate, hippocampal plasticity, and cognitive behavior","volume":"35","author":"Potter","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2019.04.031_bib116","doi-asserted-by":"crossref","first-page":"10592","DOI":"10.1523\/JNEUROSCI.1107-14.2014","article-title":"Reduction of brain kynurenic acid improves cognitive function","volume":"34","author":"Kozak","year":"2014","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.biopsych.2019.04.031_bib117","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s00213-011-2539-2","article-title":"Acute elevations of brain kynurenic acid impair cognitive flexibility: Normalization by the alpha 7 positive modulator galantamine","volume":"220","author":"Alexander","year":"2012","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.biopsych.2019.04.031_bib118","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.schres.2004.01.013","article-title":"Effects of typical and atypical antipsychotics on human glycine transporters","volume":"71","author":"Williams","year":"2004","journal-title":"Schizophr Res"},{"key":"10.1016\/j.biopsych.2019.04.031_bib119","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/S0006-3223(98)00367-9","article-title":"A\u00a0placebo-controlled crossover trial of D-cycloserine added to clozapine in patients with schizophrenia","volume":"45","author":"Goff","year":"1999","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2019.04.031_bib120","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1111\/j.1476-5381.2011.01638.x","article-title":"Clozapine, but not haloperidol, enhances glial D-serine and L-glutamate release in rat frontal cortex and primary cultured astrocytes","volume":"165","author":"Tanahashi","year":"2012","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.biopsych.2019.04.031_bib121","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0920-9964(01)00220-1","article-title":"D-cycloserine added to risperidone in patients with primary negative symptoms of schizophrenia","volume":"56","author":"Evins","year":"2002","journal-title":"Schizophr Res"},{"key":"10.1016\/j.biopsych.2019.04.031_bib122","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1176\/appi.ajp.159.3.480","article-title":"Placebo-controlled trial of D-cycloserine added to convential neuroleptics, olanzapine, or risperidone in schizophrenia","volume":"159","author":"Heresco-Levy","year":"2002","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2019.04.031_bib123","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1176\/ajp.156.1.145","article-title":"Effect of clozapine and adjunctive high-dose glycine in treatment-resistant schizophrenia","volume":"156","author":"Potkin","year":"1999","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2019.04.031_bib124","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1176\/appi.ajp.157.5.826","article-title":"Placebo-controlled trial of glycine added to clozapine in schizophrenia","volume":"157","author":"Evins","year":"2000","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2019.04.031_bib125","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1176\/ajp.156.11.1822","article-title":"D-serine added to clozapine for the treatment of schizophrenia","volume":"156","author":"Tsai","year":"1999","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2019.04.031_bib126","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1192\/bjp.169.5.610","article-title":"Double-blind, placebo-controlled, crossover trial of glycine adjuvant therapy for treatment-resistant schizophrenia","volume":"169","author":"Heresco-Levy","year":"1996","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.biopsych.2019.04.031_bib127","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.biopsych.2017.12.006","article-title":"Sodium benzoate, a D-amino acid oxidase inhibitor, added to clozapine for the treatment of schizophrenia: A randomized, double-blind, placebo-controlled trial","volume":"84","author":"Lin","year":"2018","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2019.04.031_bib128","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2174\/1570159X14666160225154812","article-title":"D-cycloserine in schizophrenia: New strategies for improving clinical outcomes by enhancing plasticity","volume":"15","author":"Goff","year":"2017","journal-title":"Curr Neuropharmacol"}],"container-title":["Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322319313307?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322319313307?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T14:23:54Z","timestamp":1777386234000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006322319313307"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":128,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S0006322319313307"],"URL":"https:\/\/doi.org\/10.1016\/j.biopsych.2019.04.031","relation":{},"ISSN":["0006-3223"],"issn-type":[{"value":"0006-3223","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeted Treatment of Individuals With Psychosis Carrying a Copy Number Variant Containing a Genomic Triplication of the Glycine Decarboxylase Gene","name":"articletitle","label":"Article Title"},{"value":"Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopsych.2019.04.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Society of Biological Psychiatry.","name":"copyright","label":"Copyright"}]}}